第 章235第5章

肝臓・胆道・膵外分泌疾患

引用文献（1）Brain PH, Barrs VR, Martin P, Baral R, White JD, Beatty JA. 2006. Feline cholecystitis and acute neutrophilic cholangitis:
clinical findings, bacterial isolates and response to treatment in six cases. Journal of Feline Medicine and Surgery 8:91-103.
（2）Callahan Clark JE, Haddad JL, Brown DC, Morgan MJ, Van Winkle TJ, Rondeau MP. 2011. Feline cholangitis: a necropsy
study of 44 cats (1986-2008). Journal of Feline Medicine and Surgery 13:570-576.
（3）Ceh L, Hauge JG, Svenkerud R, Strande A. 1976. Glycogenosis type III in the dog. Acta Veterinaria Scandinavica 17:210-222.
（4）Day MJ. 1998. Immunohistochemical characterization of the lesions of feline progressive lymphocytic cholangitis/cholangiohepatitis. Journal of Comparative Pathology 119:135-147.
（5）Fragkou FC, Adamama-Moraitou KK, Poutahidis T, Prassinos NN, Kritsepi-Konstantinou M, Xenoulis PG, Steiner JM, LidburyJA, Suchodolski JS, Rallis TS. 2016. Prevalence and clinicopathological features of triaditis in a prospective case series ofsymptomatic and asymptomatic cats. Journal of Veterinary Internal Medicine 30:1031-1045.
（6）Gagne JM, Armstrong PJ, Weiss DJ, Lund EM, Feeney DA, King VL. 1999. Clinical features of inflammatory liver disease incats: 41 cases (1983-1993). Journal of the American Veterinary Medical Association 214:513-516.
（7）Gagne JM, Weiss DJ, Armstrong PJ. 1996. Histopathologic evaluation of feline inflammatory liver disease. Veterinary
Pathology 33:521-526.
（8）Graca R, Messick J, McCullough S, Barger A, Hoffmann W. 2005. Validation and diagnostic efficacy of a lipase assay using
the substrate 1,2-0-dilauryl-racglycero glutaric acid-(6’methyl resorfun)-ester for the diagnosis of acute pancreatitis in dogs.
Veterinary Clinical Pathology 34:39-43.
（9）Gregory BL, Shelton GD, Bali DS, Chen YT, Fyfe JC. 2007. Glycogen storage disease type IIIa in curly-coated retrievers.
Journal of Veterinary Internal Medicine 21:40-46.
（10）Hirose N, Uchida K, Kanemoto H, Ohno K, Chambers JK, Nakayama H. 2014. A retrospective histopathological survey on
canine and feline liver diseases at the University of Tokyo between 2006 and 2012. The Journal of Veterinary MedicalScience 76:1015-1020.
（11）Hirsch VM, Doige CE. 1983. Suppurative cholangitis in cats. Journal of the American Veterinary Medical Association
182:1223-1226.
（12）Hunt GB. 2004. Effect of breed on anatomy of portosystemic shunts resulting from congenital diseases in dogs and cats: areview of 242 cases. Australian Veterinary Journal 82:746-749.
（13）Huth SP, Relford RL, Steiner JM, Strong-Townsend MI, Williams DA. 2010. Analytic validation of an ELISA for themeasurement of canine pancreatic-specific lipase. Veterinary Clinical Pathology 39:346-353.
（14）Ishioka K, Hayakawa N, Nakamura K, Terashima K. 2011. Patient-side assay of lipase activity correlating with pancreatic
lipase immunoreactivity in the dog. The Journal of Veterinary Medical Science 73:1481-1483.
（15）Kishnani PS, Bao Y, Wu JY, Brix AE, Lin JL, Chen YT. 1997. Isolation and nucleotide sequence of canine glucose-6phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia. Biochemical and MolecularMedicine 61:168-177.
（16）Lucke VM, Davies JD. 1984. Progressive lymphocytic cholangitis in the cat. Journal of Small Animal Practice 25:249-260.
（17）町田 登 監訳．2010. 犬および猫の肝疾患分類に関する世界小動物獣医師会標準化委員会の指針概要．犬と猫の肝胆道系疾患の病態と診断・治療，1-22，インターズー．
（18）町田 登 監訳． 2010. 胆嚢および胆管樹の疾患．犬と猫の肝胆道系疾患の病態と診断・治療，141-194，インターズー．
（19）日本獣医病理学専門家協会 編．2010. 消化器，動物病理学各論，133-257，文永堂出版．
（20）Otte CM, Penning LC, Rothuizen J, Favier RP. 2013. Retrospective comparison of prednisolone and ursodeoxycholic acidfor the treatment of feline lymphocytic cholangitis. The Veterinary Journal 195:205-209.
（21）Otte CM, Rothuizen J, Favier RP, Penning LC. Vreman S. 2014. A morphological and immunohistochemical study of theeffects of prednisolone or ursodeoxycholic acid on liver histology in feline lymphocytic cholangitis. Journal of Feline

Medicine and Surgery 16:796-804.

第 章

24

5（22）Peters LM, Glanemann B, Garden OA, Szladovits B. 2016. Cytological findings of 140 bile samples from dogs and cats andassociated clinical pathological data. Journal of Veterinary Internal Medicine 30:123-131.
（23）Richard W, Nelson C, Couto G. 2019. Hepatobiliary diseases in the dog. Small Animal Internal Medicine 6th ed., Elsevier
Health Sciences. E-book.
（24）Rothuizen J, Bunch S, Charles J, Cullen J, Desmet V, Szatmari V, Twedt D, Ted van den Ingh, Tom van Winkle, Washabau R.
2006. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases, Elsevier.
（25）Ruland K, Fischer A, Hartmann K. 2010. Sensitivity and specificity of fasting ammonia and serum bile acids in thediagnosis of portosystemic shunts in dogs and cats. Veterinary Clinical Pathology 39:57-64.
（26）Specht A, Fiske L, Erger K, Cossette T, Verstegen J, Campbell-Thompson M, Struck MB, Lee YM, Chou JY, Byrne BJ, Correia
CE, Mah CS, Weinstein DA, Conlon TJ. 2011. Glycogen storage disease type Ia in canines: a model for human metabolic andgenetic liver disease. Journal of Biomedicine and Biotechnology 2011: 646257.
（27）Spillmann T. 2014. Pancreatitis: etiology and pathophysiology. Small Animal Internal Medicine 5th ed. (Nelson RW, Couto
CG eds), 1681-1682, Elsevier.
（28）Steiner JM, Newman SJ, Xenoulis PG, Woosley K, Suchodolski J, Williams D, Barton L. 2008. Sensitivity of serum markers
for pancreatitis in dogs with macroscopic evidence of pancreatitis. Veterinary therapeutics: research in applied veterinary
medicine 9:263-273.
（29）Steiner JM, Wilson BG, Williams DA. 2004. Development and analytic validation of a radioimmunoassay for themeasurement of feline pancreatic lipase immunoreactivity in serum. Canadian Journal of Veterinary Research 68:309-314.
（30）Stockham SL, Scott MA. 2008. Enzyme activity: cavitary effusions. Fundamentals of Veterinary Clinical Pathology 2nd ed.
(Stockham SL, Scott MA eds), 862, Blackwell Publishing.
（31）Tivers M, Lipscomb V. 2011. Congenital portosystemic shunts in cats: surgical management and prognosis. Journal ofFeline Medicine and Surgery 13:185-194.
（32）Twedt DC, Cullen J, McCord K, Janeczko S, Dudak J, Simpson K. 2014. Evaluation of fluorescence in situ hybridization forthe detection of bacteria in feline inflammatory liver disease. Journal of Feline Medicine and Surgery 16:109-117.
（33）Warren A, Center S, McDonough S, Chiotti R, Goldstein R, Jacobsen M, Rowland P, Simpson K. 2011. Histopathologic
features, immunophenotyping, clonality, and eubacterial fluorescence in situ hybridization in cats with lymphocytic
cholangitis/cholangiohepatitis. Veterinary Pathology 48:627-641.
（34）Washabau RJ. 2013. Necrosis and inflammation: feline. Canine and Feline Gastroenterology (Washabau RJ, Day MJ eds.),821-829, Elsevier.
（35）Xenoulis PG, Steiner JM. 2013. Diagnostic evaluation of the pancreas. Canine and Feline Gastroenterology (Washabau RJ,Day MJ eds), 803-812, Elsevier.
（36）Xenoulis PG, Steiner JM. 2013. Necrosis and inflammation: Canine. Canine and Feline Gastroenterology (Washabau RJ,Day MJ eds), 812-821, Elsevier.